Topical and intranasal analgesic therapy in a woman with refractory postherpetic neuralgia

Kenneth Hohmeier, Lyndsey M. Almon

Research output: Contribution to journalArticle

Abstract

A patient-specific, stepped approach to topical and intranasal analgesic pharmacotherapy was effective in reducing refractory postherpetic neuralgia (PHN) not responding to the current standard of care for PHN. The use of topical analgesic therapy allowed for higher concentrations of medication locally while reducing the likelihood of systemic side effects common to the drugs used. No adverse effects were noted for either topical or intranasal drug therapy. The patient-specific, stepped approach resulted in clinically significant decreases in pain on visual analog scale (VAS), with the use of intranasal ketamine 10% solution and topical gabapentin 6%, ketoprofen 10%, lidocaine 5%, and ketamine 10% cream.

Original languageEnglish (US)
Article number392874
JournalCase Reports in Medicine
Volume2015
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Postherpetic Neuralgia
Ketamine
Analgesics
Ketoprofen
Drug Therapy
Pain Measurement
Standard of Care
Lidocaine
Therapeutics
Pharmaceutical Preparations
gabapentin

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Topical and intranasal analgesic therapy in a woman with refractory postherpetic neuralgia. / Hohmeier, Kenneth; Almon, Lyndsey M.

In: Case Reports in Medicine, Vol. 2015, 392874, 01.01.2015.

Research output: Contribution to journalArticle

@article{8832417ac2bd4271a8a7843178e4ab8c,
title = "Topical and intranasal analgesic therapy in a woman with refractory postherpetic neuralgia",
abstract = "A patient-specific, stepped approach to topical and intranasal analgesic pharmacotherapy was effective in reducing refractory postherpetic neuralgia (PHN) not responding to the current standard of care for PHN. The use of topical analgesic therapy allowed for higher concentrations of medication locally while reducing the likelihood of systemic side effects common to the drugs used. No adverse effects were noted for either topical or intranasal drug therapy. The patient-specific, stepped approach resulted in clinically significant decreases in pain on visual analog scale (VAS), with the use of intranasal ketamine 10{\%} solution and topical gabapentin 6{\%}, ketoprofen 10{\%}, lidocaine 5{\%}, and ketamine 10{\%} cream.",
author = "Kenneth Hohmeier and Almon, {Lyndsey M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1155/2015/392874",
language = "English (US)",
volume = "2015",
journal = "Case Reports in Medicine",
issn = "1687-9627",
publisher = "Hindawi Limited",

}

TY - JOUR

T1 - Topical and intranasal analgesic therapy in a woman with refractory postherpetic neuralgia

AU - Hohmeier, Kenneth

AU - Almon, Lyndsey M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - A patient-specific, stepped approach to topical and intranasal analgesic pharmacotherapy was effective in reducing refractory postherpetic neuralgia (PHN) not responding to the current standard of care for PHN. The use of topical analgesic therapy allowed for higher concentrations of medication locally while reducing the likelihood of systemic side effects common to the drugs used. No adverse effects were noted for either topical or intranasal drug therapy. The patient-specific, stepped approach resulted in clinically significant decreases in pain on visual analog scale (VAS), with the use of intranasal ketamine 10% solution and topical gabapentin 6%, ketoprofen 10%, lidocaine 5%, and ketamine 10% cream.

AB - A patient-specific, stepped approach to topical and intranasal analgesic pharmacotherapy was effective in reducing refractory postherpetic neuralgia (PHN) not responding to the current standard of care for PHN. The use of topical analgesic therapy allowed for higher concentrations of medication locally while reducing the likelihood of systemic side effects common to the drugs used. No adverse effects were noted for either topical or intranasal drug therapy. The patient-specific, stepped approach resulted in clinically significant decreases in pain on visual analog scale (VAS), with the use of intranasal ketamine 10% solution and topical gabapentin 6%, ketoprofen 10%, lidocaine 5%, and ketamine 10% cream.

UR - http://www.scopus.com/inward/record.url?scp=85032634148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032634148&partnerID=8YFLogxK

U2 - 10.1155/2015/392874

DO - 10.1155/2015/392874

M3 - Article

AN - SCOPUS:85032634148

VL - 2015

JO - Case Reports in Medicine

JF - Case Reports in Medicine

SN - 1687-9627

M1 - 392874

ER -